| |
| |
|
| Insider
Information: |
Cundy Kenneth C |
| Relationship: |
Chief Scientific Officer |
| City: |
Santa Clara |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
47,519 |
|
|
Indirect Shares
|
700 |
|
|
| Direct
Value |
$8,100 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
48,219 |
|
|
| Total
Value |
$8,100 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xenoport Inc |
XNPT |
SVP, Preclinical Devel... |
2012-01-30 |
37,519 |
2010-02-24 |
700 |
Premium* |
|
|
Cohbar Inc |
CWBR |
Chief Scientific Officer |
2021-08-11 |
10,000 |
2015-05-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
131 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2005-11-16 |
4 |
B |
$8.93 |
$15,119 |
D/D |
1,694 |
56,322 |
2.74 |
- |
|
| XNPT |
Xenoport Inc |
officerTitle |
• – – |
2005-11-28 |
4 |
B |
$13.00 |
$9,100 |
I/I |
700 |
700 |
1.99 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2006-12-22 |
4 |
AS |
$24.86 |
$25,008 |
D/D |
(1,000) |
58,211 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-01-03 |
4 |
AS |
$24.07 |
$24,303 |
D/D |
(1,000) |
57,211 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-02-01 |
4 |
AS |
$23.86 |
$24,036 |
D/D |
(1,000) |
56,211 |
0 |
- |
|
| XNPT |
Xenoport Inc |
officerTitle |
• – – |
2007-03-01 |
4 |
AS |
$24.96 |
$25,228 |
D/D |
(1,000) |
55,211 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-04-02 |
4 |
AS |
$27.52 |
$27,806 |
D/D |
(1,000) |
54,211 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-04-25 |
4 |
AS |
$36.29 |
$34,096 |
D/D |
(900) |
53,311 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-04-26 |
4 |
AS |
$44.24 |
$4,424 |
D/D |
(100) |
53,211 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-05-01 |
4 |
AS |
$41.10 |
$83,396 |
D/D |
(2,000) |
51,211 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-05-22 |
4 |
OE |
$1.50 |
$7,500 |
D/D |
5,000 |
57,275 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-05-22 |
4 |
S |
$42.91 |
$214,550 |
D/D |
(5,000) |
52,275 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-05-30 |
4 |
AS |
$45.00 |
$90,000 |
D/D |
(2,000) |
50,275 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-06-01 |
4 |
AS |
$44.80 |
$112,541 |
D/D |
(2,500) |
47,775 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-06-04 |
4 |
AS |
$45.00 |
$67,500 |
D/D |
(1,500) |
46,275 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-07-02 |
4 |
AS |
$44.64 |
$89,690 |
D/D |
(2,000) |
44,275 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-07-03 |
4 |
AS |
$45.00 |
$90,000 |
D/D |
(2,000) |
42,275 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-08-01 |
4 |
AS |
$42.76 |
$86,040 |
D/D |
(2,000) |
40,275 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-09-04 |
4 |
AS |
$41.52 |
$83,659 |
D/D |
(2,000) |
38,275 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-09-18 |
4 |
AS |
$45.00 |
$90,000 |
D/D |
(2,000) |
36,275 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-10-01 |
4 |
AS |
$48.46 |
$147,769 |
D/D |
(3,000) |
33,275 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-10-01 |
4 |
AS |
$48.47 |
$49,254 |
D/D |
(1,000) |
32,275 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-11-01 |
4 |
AS |
$48.23 |
$148,406 |
D/D |
(3,000) |
29,275 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-11-01 |
4 |
AS |
$48.01 |
$49,110 |
D/D |
(1,000) |
28,275 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-12-03 |
4 |
AS |
$51.61 |
$159,063 |
D/D |
(3,000) |
25,275 |
0 |
- |
|
131 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
